Evidence map›Paper›PMID 42829333›Full record

ArticlemAbs2026

Bispecific antibodies that engage pIgR enrich in mucosa in cynomolgus monkeys.

Kelsie Marks, Nirav Shah, Ly Pham, Jun Chen, Ian White, Krista Burke, Peter Garrett, Mathieu Marella, Prathap Nagaraja Shastri, Brian Geist and 4 more

Abstract read
In one paragraph

Article in mAbs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kelsie MarksJ&J Innovative Medicine, La Jolla, CA, USA.
Nirav ShahJ&J Innovative Medicine, Spring House, PA, USA.
Ly PhamJ&J Innovative Medicine, La Jolla, CA, USA.
Jun ChenJ&J Innovative Medicine, Spring House, PA, USA.
Ian WhiteJ&J Innovative Medicine, Spring House, PA, USA.
Krista BurkeJ&J Innovative Medicine, Spring House, PA, USA.
Peter GarrettJ&J Innovative Medicine, Spring House, PA, USA.
Mathieu MarellaJ&J Innovative Medicine, La Jolla, CA, USA.
Prathap Nagaraja ShastriJ&J Innovative Medicine, Spring House, PA, USA.
Brian GeistJ&J Innovative Medicine, Spring House, PA, USA.
Partha ChowdhuryJ&J Innovative Medicine, Spring House, PA, USA.
Vinicius CarreiraJ&J Innovative Medicine, La Jolla, CA, USA.
Wan Cheung CheungJ&J Innovative Medicine, Spring House, PA, USA.
Adam ZwolakJ&J Innovative Medicine, Spring House, PA, USA.ORCID 0000-0001-6861-9078

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Therapeutic antibodies have limited access to barrier‑protected compartments such as the brain, lung and gastric mucosa, and kidney lumen, constraining their effectiveness in many diseases. Approaches using a bispecific antibody that targets a transcytosing receptor such as the polymeric Ig receptor (pIgR) can result in significant enrichment of IgG-based therapeutics across from blood into mucosal or mucosal lining. The polymeric Ig receptor is expressed in epithelial layers in many tissues, but differences in expression patterns across species represent a challenge in validating preclinical

Indexed as

Antibodies, BispecificReceptors, Polymeric ImmunoglobulinAnimalsHumansImmunoglobulin GLungMacaca fascicularisMiceTranscytosisAntibodies, BispecificImmunoglobulin GReceptors, Polymeric ImmunoglobulinAntibodybispecificmucosapIgR

Identifiers

PMID42829333
PMCPMC13644599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.